This course is designed to improve the participant’s understanding of the evolution and processes that underlie the practice of hyperbaric medicine. Hyperbaric oxygen treatment (HBOT) treatment was first used to combat illnesses related decompression and altitude sickness. The participants will then gain an introductory understanding of HBOT and how this cutting-edge treatment can ameliorate tissue damage caused by COVID-19, particularly when used in conjunction with other therapies as holistic treatment.

Course Objectives

By the end of the course, a successful learner will be able to:

• Define hyperbaric medicine, including the mechanisms that drive this approach to treatment
• Explain the timeline for the evolution of hyperbaric medicine, from root philosophies to current practice
• Outline the key processes involved in current hyperbaric medicine
• Determine how Hypoxia-Inducible Factor 1 Alpha (HIF-1α) influences tissue healing
• Describe the Hyperoxic-Hypoxic Paradox as it relates to tissue healing
• List possible disease conditions that would benefit from HBOT

Check out our other offerings in this series!

• Long COVID Treatment with Hyperbaric Oxygen Therapy
• Post-Stroke Recovery
• Treatment of Traumatic Brain Injury and Post-Concussion Syndrome

Evidence In Motion is an AOTA Approved Provider of professional development. PD activity approval ID# 9612. This Distance learning-independent activity is offered at .1 CEUs Introductory, OT Service Delivery, Foundational Knowledge. AOTA does not endorse specific course content, products, or clinical procedures.

HBOT: Hyperbaric Medicine: Then, Now and How has been approved for 1 continuing education hours by PTPN, which is an organization recognized by the Physical Therapy Board of California to approve courses for continuing education competency hours. If you have questions or concerns, please contact PTPN 800-766-7876 and ask for the Quality Assurance Department or CEO.